Next generation sequencing informatics (2)

Next Generation Sequencing (NGS) Informatics Market to be Worth $4.3 Billion by 2030

Global NGS Informatics Market - 2023 to 2030 Meticulous Research has published a new report titled "Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030." The report predicts that the NGS informatics market will grow to $4.3 billion by 2030, with a CAGR of 15.4% during the forecast period. Growth factors include rising R&D investments by pharmaceutical and biotechnology firms, increasing cancer and genetic disorder cases, greater utilization of NGS in diagnostics and precision medicine, technological advancements in NGS informatics, and government initiatives for large-scale genomic projects. However, concerns over data confidentiality are restraining growth. The growing adoption of NGS informatics tools in hospitals and clinical labs and the increasing use of bioinformatics and genomic data management solutions for large-scale data analysis are expected to create growth opportunities for market participants. However, a major challenge is the lack of skilled professionals to operate NGS informatics tools. Next Generation Sequencing (NGS) Informatics Market: Future Outlook The market is segmented by Offering (Software [Data Analysis Software, Data Interpretation and Reporting Tools, Data Storage and Computing Tools, Laboratory Information Management Systems {LIMS}], Deployment Mode [Web and Cloud-based, On-premise], NGS Informatics Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

Global NGS Informatics Market - 2023 to 2030 Services); Application (Disease Diagnoses, Biomarker Discovery, Drug Discovery, Precision Medicine, Agriculture and Animal Research); End User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic & Research Institutes, Other End Users); and Geography. The study evaluates competitors and analyzes the market at regional and country levels. Offering Segment In 2023, the software segment is expected to hold the largest market share in NGS informatics due to software's ability to process, store, and share large NGS and genomic datasets efficiently and securely, as well as the rising demand for scalable genomic data storage. Application Segment The market includes disease diagnoses, biomarker discovery, drug discovery, precision medicine, agriculture, and animal research. In 2023, the drug discovery segment is projected to hold the largest market share, driven by the decreasing cost of sequencing, the capability of NGS informatics to detect genetic mutations, and increased R&D expenditure for new drug discovery. End User Segment The NGS informatics market is divided into pharmaceutical & biotechnology companies, hospitals and diagnostic laboratories, academic & research institutes, and other end users. Pharmaceutical & biotechnology companies are expected to dominate the market in 2023 due to the increasing use of sequencing information, high R&D activities, rising outsourcing of R&D projects, and decreasing sequencing costs. Geographic Analysis The report covers major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to lead the NGS informatics market in 2023, followed by Europe and Asia-Pacific. The U.S. is anticipated to be the largest market in North America, driven by high R&D expenditure, the presence of key market players, supportive government initiatives, extensive NGS-based research applications, and favorable reimbursement scenarios for NGS tests. Key Players The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.). Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

Global NGS Informatics Market - 2023 to 2030 Download Sample Report Here @ https://www.meticulousresearch.com/download- sample-report/cp_id=3483 Key questions answered in the report: Which are the high-growth market segments in terms of offering, application, end user, and region/country? What was the historical market size for next generation sequencing (NGS) informatics across the globe? What are the market forecasts and estimates for the period 2023 2030? What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market? Who are the major players in the global next generation sequencing (NGS) informatics market? How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market? What are the recent developments in the next generation sequencing (NGS) informatics market? What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market? What are the geographical trends and high growth regions/countries? Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com